Soft-tissue sarcomas and reconstruction options: Twenty-two years of experience

Othon Papadopoulos, Petros Konofaos, Chrisostomos Chrisostomidis, Elina Papadimitraki, Alexandros Stratigos, Alkiviadis Kostakis

Research output: Contribution to journalArticlepeer-review


Soft tissue sarcomas (STS) are particularly rare malignancies that constitute less than 1% of all malignancies. In recent years, prognostic clinical factors have been defined that help to stratify patients regarding their risk for local and distant recurrence and death from disease. Tumor grade, size, depth, completeness of resection, and presentation status are among the independent prognostic factors.At present, the treatment of these tumors constitutes a wide or marginal excision, adequate primary reconstruction, and radiotherapy. Surgery has generally been recommended as the primary method of treatment for achieving local control. Modern reconstructive surgery, especially musculocutaneous, either pedicle or free flaps, has made more extensive resections possible, while providing acceptable cosmetic and functional results.This study deals with our experience in the treatment of resectable STS with selective combination of treatment modalities.

Original languageEnglish (US)
Pages (from-to)644-648
Number of pages5
JournalAnnals of plastic surgery
Issue number6
StatePublished - Jun 2006
Externally publishedYes


  • Soft-tissue sarcoma
  • Surgical treatment

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Soft-tissue sarcomas and reconstruction options: Twenty-two years of experience'. Together they form a unique fingerprint.

Cite this